Concepedia

Safety and Antiviral Activity of Albinterferon Alfa-2b in Prior Interferon Nonresponders With Chronic Hepatitis C

David R. Nelson, Vinod K. Rustgi, Vijayan Balan, Mark Sulkowski, Gary L. Davis, Andrew J. Muir, Louis R. Lambiase, Rolland C. Dickson, Russell H. Weisner, Michele Fiscella,

Clinical Gastroenterology and Hepatology · 2008 · 40 citations · 13 references

DOI

Concepts

References

13

The CES-D Scale

Lenore Sawyer Radloff · Applied Psychological Measurement · 1977 · 53.3K citations · Full text

, , +17

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Michael Fried, Mitchell L. Shiffman, K. Rajender Reddy et al. · New England Journal of Medicine · 2002 · 6.4K citations

, , +17

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Michael P. Manns, John G. McHutchison, Stuart C. Gordon et al. · The Lancet · 2001 · 6.1K citations

, , +17

Projecting future complications of chronic hepatitis C in the United States

Gary L. Davis · Liver Transplantation · 2003 · 579 citations · Full text

, , +14

Peginterferon Alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment[1], [2] and [3] 1 2 3☆

Mitchell L. Shiffman, Adrian M. Di Bisceglie, Karen L. Lindsay et al. · Gastroenterology · 2004 · 450 citations · Full text

, , +16